ANAKINRA
anakinra 100 mg/0.67 mL injection, 28 x 0.67 mL syringes
ANAKINRA (10264F)
10264F
Manner of administration:Injection
Restriction 5450
Indication: Moderate to severe cryopyrin associated periodic syndromes (CAPS)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 28 | # of repeats: 5 | DPMQ: $1,146.64 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Kineret | |||||
